Invesco
CRMD icon

Invesco’s CorMedix CRMD Stock Holding History

Invesco’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Sell
45,360
-7,359
-14% -$58.1K ﹤0.01% 3383
2026
Q1 		$358K Buy
52,719
+3,213
+6% +$23.8K ﹤0.01% 3276
2025
Q4 		$576K Sell
49,506
-407,402
-89% -$4.5M ﹤0.01% 3148
2025
Q3 		$5.31M Buy
456,908
+279,963
+158% +$3.38M ﹤0.01% 2204
2025
Q2 		$2.18M Sell
176,945
-112,165
-39% -$1.24M ﹤0.01% 2544
2025
Q1 		$1.78M Buy
289,110
+264,407
+1,070% +$2.74M ﹤0.01% 2580
2024
Q4 		$200K Buy
24,703
+3,784
+18% +$37.8K ﹤0.01% 3516
2024
Q3 		$169K Sell
20,919
-631
-3% -$3.42K ﹤0.01% 3548
2024
Q2 		$93.3K Sell
21,550
-11,391
-35% -$57.9K ﹤0.01% 3761
2024
Q1 		$140K Buy
32,941
+3,516
+12% +$12.2K ﹤0.01% 3711
2023
Q4 		$111K Sell
29,425
-27,964
-49% -$96.2K ﹤0.01% 3673
2023
Q3 		$212K Buy
57,389
+28,091
+96% +$112K ﹤0.01% 3573
2023
Q2 		$116K Buy
+29,298
New +$145K ﹤0.01% 3700
2022
Q2 		– Sell
-10,675
Closed -$58K – 4058
2022
Q1 		$58K Sell
10,675
-228
-2% -$1.04K ﹤0.01% 3917
2021
Q4 		$50K Sell
10,903
-1,161
-10% -$5.76K ﹤0.01% 3981
2021
Q3 		$56K Buy
+12,064
New +$70.3K ﹤0.01% 3997
2016
Q2 		– Sell
-2,299
Closed -$30K – 3689
2016
Q1 		$30K Sell
2,299
-168
-7% -$1.63K ﹤0.01% 3690
2015
Q4 		$25K Buy
2,467
+95
+4% +$1.09K ﹤0.01% 3730
2015
Q3 		$24K Buy
2,372
+29
+1% +$447 ﹤0.01% 3770
2015
Q2 		$45K Buy
+2,343
New +$80.4K ﹤0.01% 3986

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Invesco's CRMD Position: Q2 2026 in Review

Invesco reduced its CorMedix (CRMD) stake by 14% in Q2 2026, selling an estimated $58.1K and leaving 45,360 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.

Invesco first reported a position in CRMD in Q2 2015 and has held it in 20 quarters since. The position peaked at $5.31M in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Invesco held 45,360 shares of CorMedix worth $356K as of Q2 2026.
  • Invesco sold 7,359 CorMedix shares in Q2 2026, an estimated $58.1K.
  • CorMedix made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3383 holding.
  • Invesco first reported a position in CorMedix in Q2 2015 and has held it in 20 quarters since.
  • Invesco's CorMedix position peaked at $5.31M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.